Brad P. Glick, DO, MPH

[Brad P. Glick, DO, MPH @BradMph]

DERMATOLOGISTS - Contact Congress Now https://t.co/1EsNKo2Yfr

[Brian S. Kim @itchdoctor]

I triple down on this

[Brian S. Kim @itchdoctor]

Congrats to this trio of immunologists!

[Mount Sinai Dermatology @MSHSDerm]

Phase I trial led by Dr. Nicholas Gulati tested topical diphencyprone for cutaneous neurofibromas in NF1. Safe and well tolerated, but only 1 of 12 patients showed partial response. A key step toward future therapies.
🔗 https://t.co/SKKPLqY6HM

@EmmaGuttman

[Brian S. Kim @itchdoctor]

If I told you I am making a tri-specific antibody that targets IL-1beta, IL-6, and TNF-alpha, every VC, investor, & pharma would run for the hills because of safety concerns.

Yet, vagus nerve stimulation can lower all of these cytokines safely and improve rheumatoid arthritis.

This is the sweet spot of neuroimmunology. Bending the therapeutic curve through immunologic tuning.

[Mount Sinai Dermatology @MSHSDerm]

Lebrikizumab rapidly reduced IL-13–driven biomarkers and improved clinical outcomes in moderate-to-severe AD. This study by @emmaguttman and colleagues confirms IL-13 as a central driver of systemic inflammation and a prime target for precision therapy

🔗 https://t.co/y2jzvGS5G5

[Brad P. Glick, DO, MPH @BradMph]

@itchdoctor @KevinJTraceyMD VIVA LA REVOLUCION… Indeed! Holy cow… That's amazing! Bg

[Brian S. Kim @itchdoctor]

Today is a landmark moment in bioelectronic medicine and neuroimmunology. @KevinJTraceyMD and colleagues identified the inflammatory reflex over 25 years ago and now (today!) have delivered a FDA-approved device to treat autoimmunity. Viva la revolucion!
https://t.co/GyoHzp5vqI

[Brian S. Kim @itchdoctor]

This is one of the most brutally honest dialogues I have had about peer review. Peer review is valuable, but why? I am not sure we ask this question enough. It shouldn’t be a mindless, perfunctory, legacy enterprise. It should clearly and maybe even quantifiably bring value. Listen to my hot 🔥 el fuego take.

[Brad P. Glick, DO, MPH @BradMph]

such great news and warm congratulations!!!

[Brian S. Kim @itchdoctor]

Kim Lab trainees have had an incredible 2025!
Lydia Zamidar accepted into MSTP (MD/PhD).
Daniel Yassky @dmyassky accepted into MD.
Victoria Le accepted into MD.
Kelsey Auyeung @kelsey_auyeung matched into Dermatology.
Anna Trier @AnnaMTrier matched into Dermatology.
Our lab continues batting 1000! Stay tuned!

[Brad P. Glick, DO, MPH @BradMph]

@MSHSDerm @IcahnMountSinai @EmmaGuttman Honored and privileged to join Dr. Mark Lebwohl who directed the session "What's new in Dermatology" on the last day of the #AAD2025, with a packed house. I discussed "What's New in Topical Therapy" Thank you to Dr Lebwohl for the invitation! @BradMpH

[John Barbieri, MD, MBA @DrJohnBarbieri]

🚨 News Alert 🚨
The FDA just released an important update regarding benzene in benzoyl peroxide products (https://t.co/Or0qA03wYO). See below for my thoughts and products to avoid:

[Brad P. Glick, DO, MPH @BradMph]

@EmmaGuttman @MSHSDerm Congratulations! Dr. @EmmaGuttman not only for a successful reception for alumni, colleagues and friends of @MSHSDerm (I attended too - it was wonderful)... but also for your multitude of successful and well attended presentations at #AAD2025 #dermtwitter #dermatology @BradMph

[Emma Guttman-Yassky @EmmaGuttman]

It was a pleasure to reunite with great friends and colleagues at #AAD2025! Last Friday, our reception for Alumni and Friends of @MSHSDerm was an astonishing success, bringing ~500 dermatologists, and pharma members that celebrated our achievements with us. Thanks to all who attended! #dermtwitter #dermatology #NIH #Icahn #mountsinai #best

[Brad P. Glick, DO, MPH @BradMph]

@SkinOfColor @DrNadaE @HCPLive Thank you @DrNadaE for your leadership in #SkinOfColorSociety and your many contributions to our specialty. Best of luck in your year as President of SOCS! @BradMph

[Skin of Color @SkinOfColor]

Hear from newly installed SOCS President @DrNadaE on the work of the #SkinofColorSociety and her vision for the future: https://t.co/lVnRLe7e6y via @hcplive

[Brad P. Glick, DO, MPH @BradMph]

@itchdoctor Amazing!! Thank you Dr Kim for your many contributions and leadership in bringing these therapeutics to our toolboxes 🧰 Bg

[Brian S. Kim @itchdoctor]

If you look at what the American Academy of Dermatology Annual Meeting looks like today, and if I could show you what it looked like in 2015, you would not believe me. Imagine a world without abrocotinib, dupilumab, lebrikizumab, tralokinumab, ruxolitinib, upadacitinib, and nemolizumab. Imagine no one caring about atopic dermatitis, prurigo nodularis, urticaria, pruritus. That was 2015. Today, itch has literally transformed the field of dermatology completely. If this sounds hyperbolic to you, then you probably missed your exit in Orlando and spent this weekend at Magic Kingdom.

[Dr. Shawn Kwatra @drshawnkwatra]

Had a great time at the 2025 American Academy of Dermatology Meeting.

I discussed the evolving landscape and new developments in chronic pruritus of unknown origin, atopic dermatitis, chronic spontaneous urticaria, & prurigo nodularis #AAD2025 #dermtwitter

[Brad P. Glick, DO, MPH @BradMph]

Honored to be nominated for Vice-President elect of the AAD - I will
1. FIGHT FOR INFLATION-BASED MEDICARE REIMBURSEMENT
2. ADVOCATE FOR PRESERVING OF OUR SCOPE OF PRACTICE
3. ENSURE MISLEADING ADVERTISING IS COMBATTED
4. PROMOTE THE VALUE OF DERMATOLOGY